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Youth with sickle cell disease (SCD) are at increased risk for poor psychosocial 
and functional outcomes due, in part, to disease effects like vaso-occlusive pain crises, 
fatigue, and poor sleep quality (Brown, 2006). A growing body of literature has examined 
temporal associations between pain, sleep quality, and mood using daily diary studies 
(Valrie, Gil, Redding-Lallinger, & Daeschner, 2007a; Valrie et al., 2019). These studies 
help to identify how symptoms are prospectively related to each other, but they are often 
limited to small sample sizes and may lack generalizability. Additionally, despite 
ubiquitous reports of fatigue among sickle cell patients, few studies have examined this 
construct in youth with SCD. The present study aims to a) replicate findings from prior 
daily diary studies to increase our understanding of their generalizability and b) examine 
novel indicators of fatigue among youth with SCD. Daily diaries assessing positive and 
negative mood, pain severity, fatigue severity, sleep quality, and use of pain medications 
were collected for eight consecutive weeks among youth. Results indicated significant 
associations between increased same-day pain and poor prior-night sleep quality, and 
increased fatigue. Poor sleep quality predicted increases in next-day fatigue levels among 
youth and moderated the temporal relationship for pain impacting next-day fatigue. 
Opioid and non-opioid medication use did not significantly affect ratings of next-day 
fatigue. Overall, most findings from prior daily diary studies were replicated, while a few 
were not. Future research using larger samples should attempt to elucidate discrepancies 
 
iv 
in findings. Novel findings from this study supported that sleep quality plays an 
important role in predicting fatigue levels and modifies the prospective pain-fatigue 
relationship. As such, sleep quality may be an important target for intervention.  Finally, 
pain medication use may not substantially contribute to prospective fatigue levels among 
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CHAPTER 1: BACKGROUND AND LITERATURE REVIEW 
Sickle cell disease (SCD) describes a group of inherited blood disorders in which 
recurrent physical complications such as pain, anemia, fatigue, inflammation, and 
infection negatively impact youth’s functioning (Brown, 2006). A growing body of 
literature has examined temporal associations between variables like pain, mood, and 
sleep quality through daily diary methods. These studies have examined how symptoms 
of sickle cell disease are related to one another and affect youth’s adjustment. Daily diary 
studies are valuable by illustrating the direction in which variables are associated, but are 
often limited to smaller-size samples that may be susceptible to lack of generalizability 
(Valrie, Gil, Redding-Lallinger, & Daeschner, 2007a; Valrie et al., 2019). Until prior 
findings can be replicated, it is unclear whether established relationships between pain 
severity, sleep quality, and mood valence generalize to youth with SCD broadly. 
Additionally, despite the large body of literature dedicated to understanding physical and 
psychosocial functioning in youth with SCD, few studies have examined factors that 
influence youth’s fatigue levels (Ameringer & Smith, 2011; Ameringer, Elswick, & 
Smith, 2014). Because fatigue is a common and debilitating symptom of SCD, this gap in 
understanding is problematic (Dampier et al., 2010). Given the limitations to the current 
literature, the goals of the present study are to examine the generalizability of previously 
established temporal associations between key variables (Ameringer & Smith, 2011; A 





Lallinger, & Daeschner, 2007a; Valrie et al., 2019) and identify novel factors 
contributing to fatigue levels in youth (Ameringer & Smith, 2011; Ameringer, Elswick, 
& Smith, 2014).  This research is guided by the biobehavioral model of fatigue and 
biopsychosocial model of pain (Ameringer & Smith, 2011; Grady, 2006; Gatchel, Peng, 
Peters, Fuchs & Turk, 2007; Brown, 2007). 
Sickle cell disease predominantly affects individuals from African descent, 
accounting for approximately 1 in every 365 African American births in the United States 
(US) (Hassel, 2010). Sickle cell disease is caused by a mutation in the β-globin gene. 
This results in polymerization of red blood cells and creation of deoxygenated sickle-
shaped blood cells that have a shorter lifespan and a rigid and viscous cell wall.  The 
decreased lifespan of the cell contributes to anemia whereas the shape and properties of 
the cell walls lead to the clumping of cells, vaso-occlusion, and inflammation of the 
arterial walls resulting in what is termed vaso-occlusive pain (Reese, Williams & 
Gladwin, 2010; Quinn, 2016).  Other symptoms of sickle cell disease include organ 
damage, increased risk for infection, cerebrovascular disease, acute chest syndrome, and 
systemic inflammation (Fuggle et al.,1996; Redding-Lallinger & Knoll, 2006; Serjant & 
Serjant, 1992).   
The severity of SCD and types of complications youth experience vary 
significantly and are related to specific genotypes and other less understood factors.  The 
most prevalent genotype associated with SCD, accounting for approximately 60% of all 
SCD patients in the US, is HbSS, commonly known as sickle cell anemia (Dampier, Ely, 
Brodecki, & O’Neal, 2002). This genotype is considered a severe variant and is 





In contrast, HbSC is associated with moderate disease severity and accounts for 30% of 
SCD patients in the US (Quinn, 2016; Reese, Williams, & Gladwin, 2010). Beta 
thalassemia mutations are less common than HbSS and HbSC genotypes but are still seen 
frequently among patients in the US (Reese et al., 2010). HbSβ0 (beta thalassemia zero) 
and HbSβ+ (beta thalassemia plus) genotypes are considered severe and moderate risk 
genotypes, respectively (Reese et al., 2010; Quinn, 2016). While genotype is commonly 
used as a proxy for disease severity, morbidity may vary considerably between 
individuals with the same genotype (Reese et al., 2010; Quinn, 2016).  
Medical interventions (e.g., oral hydroxyurea, transfusion therapy) effectively 
reduce sickle cell symptom severity, but children and adolescents still suffer from 
frequent complications that affect day-to-day functioning. Of these symptoms, vaso-
occlusive pain is known to be the most prevalent and debilitating complication 
experienced by youth and has been most extensively studied (Brandow, Zappie, & 
Stucky, 2017; Stinsor & Naser, 2003). Less is known about how fatigue impacts youth 
with SCD, although accumulating literature suggests that fatigue is a primary concern 
and source of significant functional impairment among patients (Ameringer et al., 2014; 
Anderson et al., 2015; Dampier et al., 2010; While & Mullins, 2004). 
The dearth of research exploring fatigue and its relation to other constructs in 
youth with SCD may be partially explained by the difficulty in defining and measuring 
the subjective, multidimensional nature of fatigue (Ameringer & Smith 2011; Ameringer 
et al., 2014; Anderson et al., 2015). Fatigue is generally agreed to consist of “an 
overwhelming sense of tiredness, lack of energy and feeling of exhaustion, associated 





p. 70; Ameringer et al., 2014). Sleep medicine has attempted to distinguish fatigue from 
daytime sleepiness or sleep propensity, defined as “one’s tendency to fall asleep” (Shen 
et al., 2006, p. 64). However, many researchers and clinicians continue to use these terms 
interchangeably (Crichton, Knight, Oaklet, Babl & Anderson, 2015; Shen et al., 2006). 
An important distinction between sleepiness and fatigue is that while restorative sleep 
improves symptoms of sleepiness, it does not improve symptoms of fatigue (Shen et al., 
2006; Hossain et al., 2005). Additionally, preliminary research supports that these 
constructs are clinically distinct, with Kaynak and colleagues (2006) demonstrating that 
symptoms of fatigue can occur in the absence of daytime sleepiness in patients with 
chronic disease and vice versa.  
In populations such as those with SCD, clinical fatigue is chronic in nature while 
acute fatigue, in contrast, is known to occur in healthy individuals after exertion and 
resolves with rest (Ameringer & Smith, 2010; Shen et al., 2006). Like pain, persistent 
fatigue is known to be influenced by behavioral, psychological, and physiological factors 
(Crichton, Knight, Oakley, Babl & Anderson, 2015). The biobehavioral model of fatigue 
contextualizes these relationships and asserts that person-level, disease-level, and 
moderating variables interact to produce unique fatigue-related outcomes (Ameringer & 
Smith, 2010; Hossain et al., 2005; Shen et al., 2006).  This model converges with the 
common conceptualization that fatigue is influenced by primary (disease-level) and 
secondary factors (person-level) (Ameringer & Smith, 2012; Maughan & Toth, 2014). In 
SCD, primary factors include inflammation, genotype, age, and anemia (Ameringer et al., 
2014; Crichton et al., 2015; Maughan & Toth, 2014) and secondary factors include sleep 





Among youth and young adults with SCD, cross-sectional research has 
demonstrated that fatigue is associated with increased school absences, greater 
internalizing symptoms, more pain, higher stress, impaired cognitive functioning, poor 
sleep quality, and decreased health-related quality of life (HRQOL) (Ameringer et al., 
2014; Anderson, Allen, Thornburg & Bonner, 2015; Dampier et al., 2010). Importantly, 
fatigue has been shown to be associated with negative psychosocial outcomes while 
controlling for disease-related variables (Anderson et al., 2015). Along similar lines, 
Ameringer and colleagues (2014) found that disease severity, age, and specific 
inflammatory markers (e.g., TNF-) did not significantly affect subjective fatigue levels 
among adolescents and young adults with SCD but that sex (female) and anemia severity 
did. Collectively, these data suggest that fatigue is a unique source of poor adjustment in 
youth beyond that of disease symptomology and that certain factors play a larger role in 
influencing the subjective experience of fatigue than others. Of these factors, pain 
appears to play a large role.    
Reinman (2019) demonstrated that pain severity predicted next-day levels of 
fatigue among youth with SCD. Specifically, increased pain levels predicted increases in 
next-day fatigue levels. Fatigue levels, in turn, were found to predict increases in next-
day pain, supporting a bidirectional relationship between pain and fatigue (Reinman, 
2019). Pain appeared to be the driving force in this relationship, with pain severity 
accounting for greater variance in next-day fatigue than the alternative. Fishbain and 
colleagues (2003) also provided compelling support for a causal relationship between 
pain and fatigue in a review of studies across a range of pain populations. Across 





general, these authors found that pain onset preceded fatigue onset and that reductions in 
pain severity reduced fatigue severity. Prospective studies reviewed provided additional 
support for a causal relationship between pain and fatigue, with symptoms of fatigue 
reliably following patients’ initial development of pain (Fishbain et al., 2003). In sickle 
cell disease specifically, the pathophysiology of vaso-occlusive pain may highlight the 
mechanisms through which this cyclic and reinforcing relationship operates.  
Pain experiences in sickle cell patients are thought to result from tissue damage 
from vaso-occlusion. In addition to the production of pain signals, blood cell adhesion 
and damage to the endothelium trigger the release of mediating cells and pro-
inflammatory cytokines (Redding-Lallinger & Knoll, 2006). Proinflammatory cells result 
in increased systemic inflammation and are strongly associated with subjective 
experiences of fatigue (de Oliveira, Sakata, Issy, Gerola & Salomao, 2011; Swain, 2000). 
Inflammation in sickle cell patients caused by vaso-occlusion subsequently increases risk 
for further vaso-occlusion and vaso-occlusive pain, suggesting that pain may predict 
onset of concomitant processes that cause fatigue and in turn, these concomitant fatigue-
related processes may contribute to the maintenance and development of pain. Given the 
nature of this debilitating cycle, interventions aimed at reducing the experience of pain 
and fatigue in youth are of great importance.  
A host of behavioral factors have been shown to influence both feelings of pain 
and fatigue and may be excellent candidates for improving function in youth. Sleep 
disorders, including restless leg syndrome, insomnia, and obstructive sleep apnea, a sleep 
–related breathing disorder, are prevalent among youth with SCD (Valrie, Gil, Redding-





1992). Sleep quality has been shown to affect pain and fatigue levels in youth with SCD 
and, as such, is a particularly important factor to evaluate (Ameringer et al., 2014; Valrie 
et al., 2007b).  
The relationship between sleep quality and pain in sickle cell patients has been 
well-studied. Longitudinal daily diary studies have elucidated a cyclic relationship 
between pain and sleep quality, with increased pain predicting poor same-night sleep 
quality and poor sleep quality predicting increased next-day pain (Valrie et al., 2007b; 
Fisher et al., 2018). This bidirectional relationship is consistent with a well-established 
model proposed by Lewin and Dalh (1999), which posits that pain interferes with sleep 
efficiency and quality and that poor sleep increases subjective perception of pain and 
pain-related interference with functional tasks (Valrie et al., 2007; Bromberg et al., 2013; 
Jacob et al., 2006; Lewin & Dahl, 1999; Palermo & Kiska, 2005). Pain is thought to 
disrupt sleep quality and efficiency for two reasons: namely, that the discomfort of pain 
disrupts sleep latency, quality, and may cause youth to wake at night and that pain can 
disrupt the internal mechanisms of sleep (Onen, Onen, Courpon & Dubray, 2005; Valrie 
et al., 2019). In the opposing direction, poor sleep is thought to affect subjective pain 
severity by precipitating a lower pain threshold and increasing sensitivity to pain (Onen 
et al., 2005; Bromberg et al., 2013). The authors of these studies have suggested that pain 
severity, rather than sleep quality, initiates this cyclic relationship (Fisher et al., 2018; 
Valrie et al., 2007b; Valrie et al., 2019).  
While a rich literature describes the relationship between sleep and pain among 
sickle cell patients, the relationship between sleep quality and fatigue levels is not well 





quality is related to fatigue levels in youth with chronic medical conditions. The noteable 
lack of data regarding this relationship could be explained by two factors. First,  
ambiguity in differentiating between fatigue and sleepiness due to poor sleep quality 
(Shen et al., 2006) could prevent researchers from conceptualizing these constructs 
separately in research studies. Second, it may be that researchers have captured the 
relationship between sleep and fatigue in current literature but have measured fatigue 
using a different proxy or related symptom (e.g., functional disability). For example, in a 
cross-sectional study involving youth with chronic and recurrent pain, disordered sleep 
was significantly related to increased functional disability (Palermo & Kiska, 2005). 
Lower levels of functional ability may be explained by high levels of fatigue (Pittion-
Vouyovitch et al., 2006), however fatigue as a mediator was not directly measured. These 
data indirectly suggest that poor sleep may affect fatigue levels in youth with chronic and 
recurrent pain. This relationship may be common across disease groups.  
Preliminary research also supports that sleep quality and fatigue are predictably 
related. Cross-sectional studies have shown that poor sleep quality and sleep disturbances 
are associated with increased levels of fatigue in patients with chronic diseases (Butbul 
Aviel et al., 2011; Crosby, 1991; Kanyak et al., 2006). These findings were replicated in 
studies involving youth with sickle cell disease (Ameringer et al., 2014). Biomarkers and 
biochemical responses also suggest that sleep and fatigue are related. Interleukins and 
TNF-α, which are elevated in patients with high levels of fatigue and pain, have been 
shown to negatively impact sleep (Ameringer & Smith, 2010; Klimas et al., 2012). In 
addition, inflammatory responses that mediate vaso-occlusive injury and are associated 





al., 2014). This cascade suggests that the relationship between poor sleep quality and 
increased levels of fatigue may occur in the presence of pain due to shared mechanisms. 
In studies examining the relationship between clinical fatigue and sleep, pain was 
commonly comorbid (Ameringer et al., 2014; Butz Aviel et al., 2011).  
Fishbain and colleagues (2003) drew attention to the important role that sleep may 
play in the pain-fatigue relationship among patients with chronic and recurrent pain. The 
authors highlighted that many of their reviewed studies failed to control for the effects of 
sleep when examining the relationship between pain and fatigue and as such, findings 
related to the relationship between pain and fatigue could be confounded (Fishbain et al., 
2003). These authors recommended that future studies control for sleep quality when 
attempting to characterize the pain-fatigue relationship. However, because sleep is known 
to influence experiences of pain and fatigue (Ameringer et al., 2014; Valrie et al., 2018) it 
is important to examine how sleep quality impacts these symptoms rather than simply 
controlling for its effect. Ameringer and Smith (2011) proposed that disrupted sleep 
mediates the relationship between pain and fatigue. However, because biological 
pathways likely underpin this relationship in sickle cell patients and research has shown 
that pain severity still influences fatigue levels while controlling for sleep quality 
(Fishbain et al., 2003), it is likely that poor sleep quality interacts with pain severity to 
influence prospective symptoms of fatigue in youth with SCD.  
Finally, when examining how pain severity, sleep quality, and fatigue levels 
interact over time, researchers must consider the effects of pain medications. Opioids are 
commonly used to treat sickle cell pain at home and in emergent settings (Stinson & 





onset of fatigue-like symptoms (Stinson & Naser, 2003). Studies exploring the 
association between pain and fatigue often fail to account for the effects of pain 
medications in data analyses and thus may report inflated or skewed levels of fatigue 
(Ameringer et al., 2014; Dampier et al., 2010; Fishbain et al., 2005). In addition, research 
has shown that opioids alter sleep structure (Dimsdale, Norman, DeJardin, & Wallace, 
2007) and therefore may contribute to poor sleep quality in youth with pain. In a 
longitudinal daily diary study, Valrie, Gil, Redding-Lallinger and Daeschner (2007b) 
demonstrated that the use of pain medication was associated with poor sleep quality, but 
that use of pain medication dampened the negative effect of pain on sleep quality (Valrie 
et al., 2007b). It appears that although analgesic pain medications may decrease pain 
severity and attenuate its impact on sleep quality, biochemical effects of opioids 
negatively impact sleep (Dimsdale, Norman, DeJardin, & Wallace, 2007; Onen et al., 
2005; Valrie et al., 2007b). While researchers investigating the pain-sleep relationship 
frequently control for use of medication (Fisher et al., 2018; Valrie et al., 2019), it is 
equally important to explore how the use of analgesics impacts daily and prospective 
levels of fatigue.  
1.1 The present study 
 In general, research has shown that pain severity, sleep quality, fatigue, and mood 
valence are temporally related in specific directions (Ameringer et al., 2014; Valrie et al., 
2007a; Valrie et al., 2019). While this research is meaningful, at present, it is unknown 
whether these findings generalize to most youth with SCD. Additionally, although 
symptoms like pain, fatigue, and poor sleep quality have been shown to negatively 





temporally related to each other. Empirical and theoretical evidence suggests that 
symptoms of pain, disrupted sleep, and fatigue may interact to produce synergistic 
negative effects for youth (Ameringer & Smith, 2010; Ameringer et al., 2014; Dampier et 
al., 2010;  Lewin & Dahl, 1999). Because fatigue is a common and debilitating symptom 
of sickle cell disease, identifying novel factors that predict fatigue in youth is important 
for future clinical interventions. The goal of this thesis is to enhance understanding of 
generaliziability of prior findings and examine novel indicators of fatigue in youth with 
sickle cell disease. Specifically, this thesis aims to: (a) replicate interrelations observed 
among sleep, fatigue, pain, and mood, in previous studies (b) examine how sleep quality 
affects the prospective pain-fatigue relationship, and (c) determine how the use of pain 
medications affects next-day fatigue levels among youth with sickle cell disease through 
daily diary methods.  
1.2 Objectives and Hypotheses 
The first objective of this thesis is to replicate findings from prior daily diary 
studies to support their generalizability to youth with SCD. Specifically, replication of 
associations and causal pathways between variables of sleep, mood, fatigue, and pain will 
be tested. 
• Hypothesis 1a: Daily levels of pain intensity will be significantly related to same-
day reduced sleep quality, increased negative mood, and increased levels of 
fatigue (Ameringer et al., 2014; Valrie, Gil, Redding-Lallinger & Daeschner, 
2007a).  
• Hypothesis 1b: Daily pain levels will predict poor same-night sleep quality 





increases in next-day pain (Valerie et al., 2019; Valrie et al., 2007a; Jacob et al., 
2006).  
The second objective is to examine the effects of sleep quality on fatigue levels in 
youth with SCD. Specifically, the effect of sleep on prospective fatigue levels and the 
prospective pain-fatigue relationship will be examined.  
• Hypothesis 2a: Poor sleep quality will predict next-day fatigue.  
• Hypothesis 2b: Poor subjective sleep quality will moderate the 
relationship between pain severity and next-day fatigue levels.  
The third objective of this study is to examine how pain medications affect 
prospective fatigue levels among youth with SCD.  
• Hypothesis 3: Use of analgesic pain medications will predict increases in 
next-day fatigue levels. Non-opioid medications (e.g., ibuprofen, Tylenol) 





CHAPTER 2: METHODS 
2.1 Participants 
 30 youth (Mage = 14.44, SD= 2.03, 53% = male) between the ages of 11 and 18 
with a clinical diagnosis of sickle cell disease were recruited from Prisma Health 
Children’s Center for Cancer and Blood Disorders (CCBD) following IRB approval from 
the University of South Carolina and Prisma Hospital. Eligible youth were identified 
through review of medical records, neuropsychological assessment reports, and 
consultation with the CCBD hematologist. Additional inclusion criteria required English 
fluency and daily access to the internet. Participants who were experiencing a medical 
crisis (e.g., surgery) at the time of recruitment that would affect their ability to participate 
were excluded from the study. Youth with major developmental disorders or significant 
cognitive impairments (e.g., those who had experienced an overt stroke) were also 
excluded due to possible limitations in their ability to provide accurate and valid self-
report data. Final inclusion criteria required youth to complete 9 or more daily diaries in 
order for researchers to draw sound inferences from longitudinal data. 
2.2 Procedure  
 Participants were recruited as part of a larger study through the Children’s Center 
for Cancer and Blood Disorders at Prisma Health Children’s Hospital after their routine 
healthcare appointment. Researchers met with eligible participants and their caregivers to 





 and caregiver informed consent, parents and youth completed baseline measures of pain 
and fatigue.  The use of daily health diaries has been established as a valid methodology 
among youth with chronic illnesses (Gil et al., 2000). Previous studies involving youth 
with SCD have utilized daily health diaries to study temporal relationships between 
variables of interest (Butz & Alexander, 1991; Gil et al., 1997; Valrie et al., 2007). 
Therefore, this design was adopted for the present study. Additional baseline measures 
were completed for descriptive purposes as part of a larger study. These measures are not 
included in the present study as they are not relevant to its purpose. Participants then 
received instructions on daily health diary completion. Participants were instructed to 
complete their diary at the same time each day for eight consecutive weeks during the 
academic school year. Each daily diary survey was expected to take between 10-15 
minutes to complete and were completed using SurveyGizmo, an online survey 
generator. Participants received an email from researchers at midday (between 1:00-
2:00pm) containing a unique URL code that would take them to their daily survey. 
Surveys could be accessed and completed on any electronic device with internet (e.g., 
tablet, computer, or smartphone). Reminder texts were sent to participants’ mobile phone 
if they had not completed their daily diary survey by 5:00pm. For every 10 diaries 
completed, participants would receive $10.00. Follow-up contacts were made if 
participants had not completed diaries for three consecutive days. After seven weeks, 
participants were contacted to set up an appointment to complete follow-up measures at 
the Children’s Center for Cancer and Blood Disorders Clinic. Participants received 





2.3 Data management  
Data were collected using SurveyGizmo, a platform with a secure interface. Each 
participant was given a unique identifier used in the daily diary study to ensure responses 
from the daily diary study could not be linked to protected health information. Principal 
investigators had access to a confidential document where study identifiers were 
connected to participant names. Data analysis was conducted using R statistical software. 
Data entries were connected using participants’ unique study identifier to ensure 
anonymity. All documents and data were stored and analyzed on computers that were 
firewall and password protected to ensure confidentiality.  
2.4 Measures 
Pain: Daily pain was measured with two items. Pain was rated on an 11-point 
numeric rating scale (NRS) anchored by zero “no pain whatsoever” and 10 “worst pain 
imaginable”. Visual-analog scales are frequently used to assess pain intensity and have 
been established to yield reliable and valid measurements of pain (Breivik et al., 2008; 
Wong & Baker, 1998). A second item assessed whether a) participants they taken any 
medications for pain and b) whether this medication was an opioid (e.g., codeine, 
morphine) or a non-opioid (e.g., ibuprofen, Tylenol) pain medication.  
 Fatigue: Daily fatigue was assessed using 3 items. Participants rated the 1) 
severity, 2) bother, and 3) interference of their fatigue on a scale from 0-10. This three-
item measure, known as the Daily Fatigue Report Form, was developed by Erickson et al. 
(2010) and used in a sample of youth receiving chemotherapy. Similar measures have 






 Sleep Quality: Sleep quality was measured with one-item. Participants rated the 
quality of their previous nights’ sleep on a 0-10 numeric rating scale (NRS) with 0 
indicating “poor” sleep and 10 indicating “ideal” sleep quality. This method of assessing 
sleep quality has been used in a number of studies including youth with SCD and is 
established as a reliable and valid measure (Bromberg, Gil & Schanberg, 2012; Valrie et 
al., 2007b).   
 Mood: Mood was assessed using the Positive and Negative Affect Schedule for 
Children (PANAS-C). This 27-item scale was developed based on personality dimensions 
of extraversion and neuroticism and measures positive affect (PA) and negative affect 
(NA). This scale has been shown to strongly relate to internalizing symptoms in youth 
and is a widely used measure of mood valence (Watson, Clark & Tellegan, 1998). It has 
demonstrated strong reliability and utility in populations of youth with chronic illness 
(Zempsky et al., 2013).  
2.5 Planned Statistical Analyses  
 Data will be analyzed using R statistical software. Data from participants who 
completed fewer than 9 daily diaries will be excluded. Preliminary bivariate correlations 
will be run to identify the strengths of intercorrelation among variables. Multilevel 
modeling analyses (MLM) will be run to evaluate the temporal relationship between 
variables of sleep quality, pain, use of pain medication, and fatigue levels. MLM analyses 
will be modeled after previous daily diary research studies having occurred within the 
past 5 years in the Pediatric Health and Neuropsychology lab (Schlenz et al., 2015; 
Reinman, 2019 <unpublished>). Specifically, models will be run in three steps. First, an 





potential covariates (e.g., age, sex, genotype, mood). Finally, predictors will be added to 
the model. Each model included a ‘Day’ and person-level variable to statistically correct 
for serial dependency of sequential days and individual differences, respectively. 
Comparative null models were run with ‘Day’ variables. R2 comparing null and 
alternative models will be computed using the following formula:  
1 – ((SD of intercept for full model + SD of residual for full model) / ((SD of intercept 
for null model + SD of residual for null model)) 
 Multilevel modeling assumptions will be evaluated using L-ratios by comparing 
fixed versus fixed and random intercepts. Normality and linearity assumptions will be 
visually evaluated by plotting scatterplots and histograms of standardized residuals from 
the models. Given the variable nature of sickle cell disease symptoms, kurtosis and skew 
in histogram plots are expected. No data will be transformed due to associated challenges 
interpreting such data. Any significant violations of assumptions warrant explanation of 
why assumptions could be violated, and results should be cautiously interpreted. Effect 
sizes were calculated.  
Addressing Hypotheses:    
H1a: Pain will be significantly related to poor sleep quality, negative mood, and 
increased levels of fatigue (Ameringer et al., 2014; Valrie et al., 2007b). To address this 
hypothesis, a multilevel model will be run looking at same-day associations between pain 
and poor sleep quality, negative mood, and fatigue level.  
H1b: Same-day pain will predict same-night sleep quality scores (Valerie et al., 
2019; Valrie et al., 2007b; Jacob et al., 2006). Specifically, increased pain scores will 





controls for mood, sex, age, and genotype and focuses on the association between pain 
scores and sleep quality that night. 
Hypothesis2a: Poor sleep quality will predict next-day fatigue. This hypothesis 
will be addressed using a lagged model focusing on the association between sleep quality 
scores and next-day fatigue levels.  
  H2b: Poor subjective sleep quality will moderate the relationship between pain 
and next-day fatigue. For this hypothesis, an interaction term between mean-centered 
pain severity scores and mean-centered sleep quality scores will be computed. A lagged 
model will be run to examine how associations between the interaction term and next-day 
fatigue scores.   
 H3:  Use of analgesic pain medications will predict increases in next-day fatigue 
levels. Non-opioid medications (e.g., ibuprofen, Tylenol) will not predict next-day fatigue 
levels.  For this analysis, a lagged model will first examine the effects of use of analgesic 
pain medication (coded as 1) on next-day fatigue scores.  Second, a lagged model will 







Table 2. 1 Sample Demographics 
 




Gender (n, %)    
Male  16 (53.3) 14 (60.9) 2 (28.6) 
Female  14 (46.7) 9 (39.1) 5 (71.4) 
Age (M, SD) 14.44 (2.03) 14.27 (1.88) 14.98 (2.57) 
Age Category (n, %)    
Child (11-12 years) 8 (26.7) 6 (26.1) 2 (28.6) 
Teen (13-18 years) 22 (73.3) 17 (73.9) 5 (71.4) 
Disease Severity    
Genotype (n, %)    
     HbSS 20 (66.7) 14 (60.9) 6 (85.7) 
     HbSC 4 (13.3) 4 (17.4) 0 (0) 
     HbSβ+ 4 (13.3) 3 (13.0) 1 (14.3) 
     HbSβ0 2 (6.7) 2 (8.7) 0 (0) 
     Other 0 (0) 0 (0) 0 (0) 
On Hydroxyurea (n, %) 22 (73.3) 16 (69.6) 6 (85.7) 
Race/Ethnicity (n, %)    
Black/African American 30 (100) 23 (100) 7 (100) 
Multiracial 1 (3.3) 1 (3.3)  0 (0) 
Insurance (n, %)    
Medicaid 21 (70) 15 (65.2) 6 (85.7) 
Military 4 (13.3) 3 (13.0) 1 (14.3) 





CHAPTER 3: RESULTS 
 Of the original 30 youth recruited in the present study, 23 youth (Mage = 14.27, 
SD= 1.88, 61% = male) between the ages of 11 and 18 with a clinical diagnosis of sickle 
cell disease completed 9 or more diaries. Youth who completed diaries differed from 
youth who did not complete diaries on several baseline characteristics. Specifically, diary 
completers reporter greater baseline fatigue levels than non-completers and diary non-
completers reported higher baseline anxiety sensitivity than diary non-completers 
(Reinman, 2019). Of the 23 youth included in the final sample data analysis, 6 were 
children (11-12 years old) and 17 were adolescents (13-18 years old). Additional 
demograpics of the sample (e.g., race/ ethnicity, genotype) can be found in Table 2.1 and 
same-day associations between variables can be found in Table 3.2.   
Multilevel models were run to address all hypotheses. Prior to running these 
analyses, model assumptions were checked and met (p<.0001). The distribution of 
residuals can be found in Appendix A and are represented in scatterplots and histograms 
for each multilevel model tested. Results are organized sequentially by hypothesis.  
First, prior research findings were tested for replication using data from the 
present study. Hypothesis 1a predicted that pain would be significantly related to poor 
sleep quality, negative mood, and increased levels of fatigue (Ameringer et al., 2014; 
Valrie et al., 2007b). The overall model used to test this hypothesis was statistically 





prior-night sleep quality t(1, 593) = -2.02, p = .043, greater fatigue levels t(1, 593) = 4.34, 
p < .001, effect size r =.18 and positive mood t(1, 593) = -2.63, p < .001 significantly 
predicted increased levels of same-day pain. These data partially supported the 
hypothesis. Unexpectedly, negative mood did not significantly predict same-day pain 
levels t(1, 593) = -0.75, p = .45, while positive mood was significantly associated with 
decreased pain severity.  
The temporal relationship between pain and sleep quality was then tested for 
replication. Hypothesis 1b posited that same-day pain would predict same-night sleep 
quality scores (Valerie et al., 2019; Valrie et al., 2007b; Jacob et al., 2006). More 
specifically, increased pain scores were hypothesized to predict poor same-night sleep 
quality. The overall model for this hypothesis was statistically significant χ2 = 67.46, p < 
.001, R2 = .503 (Table 1.2). However, contrary to expectations and prior research 
findings, same-day pain t(1, 591) = -0.42, p = .68, did not predict sleep quality scores 
while controlling for fatigue levels and positive and negative affect. These findings 
suggest that controlling for the effect of fatigue levels and mood may change our 
understanding of this relationship. 
Second, novel associations between sleep quality and fatigue were examined. 
Hypothesis 2a asserted that poor sleep quality would predict next-day fatigue. The overall 
model for this hypothesis was statistically significant, χ2 = 90.28, p < .001, R2 = .25 
(Table 2.1). Poor previous night’s sleep quality t(1, 593) = -3.64, p < .001, greater same-
day pain severity t(1, 593) = 5.33, p < .001, and same-day negative affect t(1, 593) = 





Collectively, these data revealed that sleep quality was not affected by same-day 
pain ratings, but that poor sleep quality predicted increased levels of fatigue. Next, 
hypothesis 2b was tested, which stated that poor subjective sleep quality would moderate 
the relationship between pain and next-day fatigue. The overall model for this hypothesis 
was statistically significant, χ2 = 71.52, p < .001, R2 = .35 (Table 2.2). Specifically, the 
interaction between previous night’s sleep quality and pain severity t(1, 593) = -1.99, p < 
.05, effect size r=0.08 predicted greater fatigue levels, while controlling for prior night’s 
sleep quality (1, 593) = -4.13,  p < .001, pain severity t(1, 593) = 3.31  p < .001, and prior 
day fatigue levels t(1, 593) = 5.56,  p < .001 (Figure 1). These findings reveal that poor 
sleep quality moderates the prospective pain-fatigue relationship among youth with SCD.  
Finally, the effects of pain medications on fatigue levels were examined. 
Hypothesis 3 predicted that the use of analgesic pain medications would predict increases 
in next-day fatigue levels and that non-opioid medications (e.g., ibuprofen, Tylenol) 
would not affect next-day fatigue levels.  The overall model for this hypothesis was 
statistically significant χ2 = 62.27, p < .001, R2 = .44 (Table 2.3). However, both opioid 
t(1, 593) = 0.58, p = .22 and non-opioid medications t(1, 593) = .51, p = .10 did not 
significantly predict next day fatigue levels. 
  
  





















M=mean, MDN=median, SD=standard deviation, R=range, F=frequency 
 
  
 M MDN SD R F 
Variable – 
 
    
Fatigue 1.104 0 1.983 11  
Pain 0.841 0 1.778 11  
Sleep Quality  7.321 8 2.546 11  
Positive Affect 36.413 36 15.913 48  
Negative Affect 17.902 15 5.129 37  
Opioid Pain Medication     0.035 (3.5%) 
Non-opioid Pain Medicati
on 
    0.064 (6.4%) 
  



























**p>.01, *p>.05, (N = 623) 
 
  
 1. 2. 3. 4. 5. 6. 
1. Pain Intensity – 
 
     
2. Sleep Quality d = -0.187** 
r = -.093** 
     
3. Fatigue Severity d =  0.222**  
r = .110** 
d =  0.247**  
r = .122** 
    
4. Positive Mood d = -0.377** 
r = -.185** 
d =  0.601**  
r = .288** 
d = -0.375  
r = .184 
   
5. Negative Mood d =  0.086  
r = .043 
d = -0.230**  
r = .114** 
d =  0.331**  
r = .163** 
d = -0.333**  
r = -.164** 
  
6. Opioid Medication Use d =  2.339**  
r = .760** 
d = -0.308**  
r = .152** 
d =  1.448**  
r = .586** 
d = -0.387**  
r = -.190** 
d =  0.149  
r = .074 
 
7. Non-opioid Pain  
    Medication Use 
d =  0.948**  
r = .428** 
d = -0.336*  
r = .166* 
d =  0.175  
r = .087 
d = -0.103  
r = -.051 
d =  0.100  
r = .050 
d = -.104**  
r = -.052** 
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Negative Affect -.10 .14 -.38, .18 -.68 .50 
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CHAPTER 4: DISCUSSION 
Adolescents with sickle cell disease experience frequent disease complications 
and increased risk for internalizing symptoms (Brown, 2007). In particular, youth are 
likely to expeirnce acute pain crises, fatigue, and disrupted sleep quality, all of which 
exert negative effects on functional ability and adjustment (Dampier et al., 2010; Valrie 
et al., 2007). To date, little research has examined whether previously established 
relationships between sleep quality, mood valence, and pain severity hold true for most 
youth with SCD. Additionally, unique predictors of fatigue in youth with SCD and how 
pain, sleep quality, and fatigue are temporally related are largely undetermined 
(Ameringer & Smith, 2011). Aligned with a biopsychocial model of pain and 
biobehavioral model of fatigue, this thesis aimed to enhance understanding of the 
generalizability of previously established relationships between biopsychosocial variables 
and identify novel indictors of fatigue. To this end, interrelations among key 
biopsychosocial variables were tested for replication, unique and moderating effects of 
sleep quality were examined, and the effect of pain medications on prospective fatigue 
levels were explored through daily diary methods.  
In general, a majority of same-day associations between variables of mood, pain 
severity, sleep quality, and fatigue demonstrated in previous research were successfully 





same-day positive mood. Conceptually, positive mood is thought to attenuate the severity 
of clinical pain experiences by increasing feelings of well-being and lowering negative 
affective reactivity to pain experiences (Finan & Garland, 2015).  As such, our are 
consistent with empirical and conceptual models of positive affect and pain. Also in line 
with prior research, greater levels of pain were associated with increased same-day levels 
of fatigue and poor prior night sleep quality (Ameringer et al., 2014; Valrie et al., 2007; 
Valrie et al., 2007b). The significant same-day association observed between pain 
severity and fatigue levels converges with previous findings from cross-sectional studies 
(Ameringer et al., 2014; Dampier et al., 2020; Gold, Mahrer, Yee, & Palermo, 2009) and 
expected relations posited by the biobehavioral model of fatigue (Ameringer & Smith, 
2011). Consistent findings across studies support that symptoms of fatigue and pain are 
predictably related and should be better understood through future research efforts. 
Additionally, these data contribute to now four daily diary studies that have demonstrated 
the negative effect of poor sleep quality on next-day pain ratings among youth with sickle 
cell disease (Fisher et al., 2018; Valrie et al., 2007a; Valrie et al., 2007b). These data 
underscore the important role that sleep plays in predicting symptoms of pain and suggest 
that sleep quality may be an important target for pain management interventions. 
Collectively, these findings provide additional support for empirical and 
theoretical associations between symptoms of fatigue, pain, poor sleep quality, and 
positive mood among sickle cell patients. Replicated associations support that previously 
established relationships likely generalize across youth with SCD. These findings are 
particularly compelling by demonstrating that expected associations between variables 





Contrary to prior research findings and expected associations, however, pain severity was 
not significantly related to same-day negative mood in this sample (Gil et al., 2003; 
Porter, Gil, Carson, Anthony, & Ready, 2000; Valrie et al., 2007b).The reason for this 
result is less clear as same-day associations between pain severity and negative mood 
have been demonstrated in both adolescents and young adults with sickle cell disease 
(Valrie et al., 2007b; Porter et al., 2000). Nonetheless, several factors may explain why 
negative mood was not significantly associated with same-day ratings of pain in the 
present study. One of these factors involves differences in participants’ age and 
developmental stage.  
Despite comparable sample sizes across daily diary studies examining negative 
mood and pain, measurement indices and participant ages differed (Porter et al., 2000; 
Valrie et al., 2008). It is possible that the relationship between negative mood and pain 
differs among younger children, aged 8-12, and adults. However, it is more likely that the 
effect of negative affect on pain severity is consistently small, rather than varied across 
developmental stages. For example, although Porter and colleagues (2000) demonstrated 
a significant same-day association between negative mood and increased pain severity 
among a group of 15 adult participants between the ages of 25 and 54, the association 
became non-significant when controlling for stress and positive affect (Porter et al., 
2000). As such, negative affect did not exert an indepdent effect on same-day pain ratings   
did not examine this association while controlling for covariates. Additionally, this 
study’s main contribution to the literature demonstrated that negative mood partially 
mediated the relationship between pain severity and poor sleep quality and poor sleep 





differences between studies, the effect of fatigue, or a non-significant independent effect 
of negative affect on pain could account for inconsistent findings.  The association 
between negative affect and pain severity may be indirect or accounted for by other 
factors.  
Measurement instrumentation could also contribute to inconsistent findings across 
studies. Specifically, some authors quantified mood dimensionally with visual analog 
scale scores falling between 0 and 1 (Valrie et al., 2007b). Other authors (Gil et al., 2003; 
Porter et al., 2000) indexed positive and negative mood separately, consistent with our 
measurement, but utilized significantly fewer items (e.g., 8 and 13). Quantifying positive 
and negative affect on the same measure when they are conceptually distinct could 
contribute to differential findings (Diener & Emmons, 1984). Future research should 
establish a gold standard measure of positive and negative affect for daily diary studies 
that yields valid and reliable findings among youth with SCD.  
Finally, it is also possible that a significant association between negative mood 
and fatigue could account for the non-significant finding between negative mood and 
pain. Theoretical models and empirical research support a strong relationship between 
negative mood and increased levels of fatigue (Ahmadi, Poormansouri, Beiranvand, & 
Sedighie, 2018; Ameringer & Smith, 2011; Ameringer et al., 2014; Lyon et al., 2014). In 
this study, negative mood was shown to influence fatigue levels at nearly the same 
strength as sleep quality. The significant relationship between negative mood and fatigue 
and non-significant relationship between negative mood and pain severity suggests that 
symptoms of fatigue could attenuate or partially account for negative mood’s effect on 





independently affects pain severity and fatigue levels (Ameringer & Smith, 2011). 
However, research has shown strong interrelation between these variables, which may 
render the predicted isolated effects of one construct on another conceptually unsound. 
Finally, it is important to consider that limitations to the current study, including a 
relatively small sample size and restricted age group, may also explain these findings. It 
may be that negative affect did not affect pain ratings among the youth in our sample due 
to an artifact or another unknown reason.  
As a whole, most previously established relationships tested in the first hypothesis 
were replicated. After replicating a significant effect of prior night’s sleep quality on 
next-day pain severity ratings, this thesis sought to examine whether pain severity 
predicted poor same-night sleep quality in the current sample. Contrary to hypothesis 1b, 
pain severity did not predict same-night sleep quality in this sample while controlling for 
the effects of fatigue and mood. These data oppose findings from several studies 
conducted with youth diagnosed with SCD, wherein poor sleep quality and increased 
pain temporally predicted the other (Fisher et al., 2018; Valrie et al., 2008; Valrie et al., 
2007; Valrie et al., 2018). Given these data, two lines of reasoning could explain 
conflicting findings. First, although two prior studies that produced findings contrary to 
ours controlled for the effects of mood on sleep quality (Valrie et al., 2008; Valrie et al., 
2018), the inclusion of fatigue in our model could possibly change the observed effect of 
pain severity on sleep quality. Second, methodological differences, such as differences in 
measurement instrumentation across studies, could contribute to differential findings. 
Before exploring these possibilities, it is important to note that the literature examining 





is mixed. While studies involving youth with SCD have consistently demonstrated a 
significant relationship between pain and same-night sleep quality, multiple studies have 
failed to demonstrate a predictive effect of pain on same-night sleep quality among youth 
with chronic pain or pain-related illnesses (Bromberg et al., 2012; Lewandowski et al., 
2010). Given this literature, it is likely that both methodological differences and an 
omitted effect of fatigue are involved in producing mixed findings across literatures.    
First, the addition of fatigue in our model predicting sleep quality could have 
rendered the effect of pain non-significant. While sleep quality is not included in the 
biobehavioral model of fatigue (Ameringer & Smith, 2011), Ameringer and colleagues 
(2014) demonstrated significant associations between disrupted or poor sleep and 
increased levels of fatigue. Additionally, the pathophysiology of fatigue and pain involve 
overlapping mechanisms and appear to reinforce the other. Therefore, pain and fatigue 
may interact or mutually influence sleep quality of youth with SCD (Butz Aviel et al., 
2011). Among cancer patients, sleep quality has been hypothesized to influence fatigue 
levels, but the reverse relationship is unclear (Ancoli-Israel, Moore, & Jones, 2001). 
Moreover, non-significant findings between pain and same-night sleep quality among 
youth with chronic pain and arthritis suggest pain intensity may be important to consider 
when exploring causal relationships (Bromberg et al., 2012; Lewandowski et al., 2010). It 
could be that severe pain disrupts sleep quality whereas mild or moderate pain does not. 
However, disentangling the effects of pain and use of pain medications on sleep quality 
remains challenging (Ancoli-Israel et al., 2001; Stinson & Naser, 2003). The relationship 





Second, methodological differences could account for conflicting findings. 
Specifically, differences in sample characteristics (age ranges) could affect observed 
results. For instance, it is possible that pain’s effect on sleep quality depends on the 
developmental stage of the youth involved (Valrie et al., 2007, 2008). There is little 
evidence to support this line of reasoning, however. Pain’s effect on sleep quality was 
replicated in an actigraphy study including same-aged participants by Valrie and 
colleageues (2018), suggesting that other methodological differences are important to 
consider. Valrie et al., (2007, 2008, 2018) quantified pain and sleep quality on a 10mm 
visual-analog scale whereas we, along with other authors (Bromberg et al., 2012; 
Lewandowski et al., 2010) utilized an 11-point numeric rating scale. Research has shown 
that, while ratings of pain on visual analog scales and numeric ratings scales reliably 
correlate with one another, ratings on these measures are distinct (Myvrik et al., 2015). 
Specifically, one study conducted with youth with SCD demonstrated that VAS and NRS 
produced similar ratings at high levels of pain but variability between pain ratings on 
these scales increased at lower levels of pain (Myrvik et al., 2015). Given that acute pain 
episodes among youth with sickle cell are variable and relatively infrequent, it is possible 
that these two methods of measuring pain and sleep differentially captured genuine 
experiences and thus, different findings could be due to measurement errors. Of note, 
Lewandowski et al. (2010) and Bromberg et al., (2012) reported a nonsignificant effect of 
pain on same-night sleep quality among youth with chronic pain using eleven-point rating 
scales to quantify pain and subjective sleep quality. Future research is needed to better 





The second overall goal of this thesis was to examine novel indicators of fatigue 
levels in youth with SCD. As such, we examined associations between youth’s sleep 
quality, use of pain medication, and fatigue levels. Hypothesis 2a, which posited that 
sleep quality would predict next-day fatigue (above and beyond prior-day fatigue levels), 
was supported. Specifically, poor sleep quality predicted increased levels of fatigue 
among youth. Same-day pain severity and negative affect also contributed to fatigue 
levels in a positive direction, but positive affect did not. These data extend prior cross-
sectional research, which had demonstrated associations between sleep and fatigue levels, 
by identifying a temporal relationship among constructs (Ameringer et al., 2014; Rogers 
& Lance, 2017). Of note, the biobehavioral model of fatigue presently does not include 
sleep quality (Ameringer & Smith, 2011). Revisions to this model may be warranted, as 
findings from the present study align with the conceptualization that poor sleep quality 
contributes to increased fatigue among patients with chronic diseases (Ancoli-Israel et al., 
2001). Research supports that inflammation resulting from increased levels of IL-6 may 
mediate the effect of poor sleep on subjective feelings of fatigue (Rohleder, Aringer & 
Boentert, 2012; Thomas, Motivala, Olmstead, & Irwin, 2010). For patients with elevated 
levels of baseline inflammation, poor sleep may exert a multiplicative effect on 
inflammatory pathways, making these patients particularly vulnerable to the effects of 
poor sleep on fatigue levels (Gutstein, 2001). Importantly, the effect of prior night’s sleep 
quality on fatigue levels was nearly identical to the effect of negative affect, which has 
long been theorized and empirically validated to influence fatigue levels across a 
multitude of studies and disease populations (Ahmadi, Poormansouri, Beiranvand, & 





such, sleep quality and negative affect may be equally significant in determining 
symptoms of fatigue. The influence of sleep quality on prospective fatigue levels among 
youth with SCD is likely underappreciated. Sickle cell patients demonstrate a high 
prevalence of sleep disorders (Samuels et al., 1992) anemia, and hypoxia, all of which 
confer increased risk for fatigue (Brown, 2006; Gutstein, 2001). Sleep quality and fatigue 
therefore, are important targets for clinical interventions given fatigue has a negative 
impact on psychosocial functioning, QOL, and academic success (Anderson, et al. 2015; 
Dampier et al., 2010; Rogers & Lance, 2017).  
The effect of sleep quality on prospective fatigue levels is also meaningful in that 
it provides support for the distinction between the two constructs (Kanyak et al., 2006; 
Shen et al., 2006). Had sleep quality demonstrated a large predictive effect on next-day 
fatigue levels, the interpretation of findings would likely be that the constructs are 
confounded. However, because the effect of sleep quality was relatively small and equal 
to those of negative affect, these data support that sleep quality plays an important but not 
all-encompassing role in affecting youth’s fatigue. Further distinguishing conceptual and 
practical characteristics between these constructs is warranted. It is important to note that 
our findings are limited in that they do not capture the cumulative impact of poor sleep 
quality over multiple nights on youth’s fatigue levels. Poor sleep quality across an 
extended period of time may differentially predict fatigue levels among youth with 
chronic illnesses (Dawson & McCulloch, 2005). Future research should examine how 
poor sleep quality cumulatively affects fatigue levels among youth with SCD.  
The relationships between pain severity, negative affect, and fatigue levels that 





Smith, 2011). Interestingly, significant associations between mood valence and fatigue 
found in our study are opposite of those in pain severity. Specifically, while negative 
mood and not positive mood affected fatigue levels, positive mood, but not negative 
mood, affected pain severity. These data suggest that despite a causal relationship 
between pain and fatigue, mood differentially impacts these symptoms.   
Of particular interest to the present study was the relationship between sleep 
quality,  fatigue, and pain severity among youth with SCD. Specifically, the temporal 
relationship between pain severity and next-day fatigue levels coupled with significant 
associaitons between these constructs and sleep spurred the examination of the 
moderating effect of sleep quality. Consistent with hypothesis 2b, sleep quality 
moderated the impact of pain on next day fatigue levels in youth. Poor sleep quality 
exacerbated the effect of pain on next-day fatigue such that youth reporting pain and poor 
sleep quality endorsed higher levels of next-day fatigue than those who reported pain but 
adequate sleep quality. Importantly, sleep quality appeared to most strongly affect next-
day fatigue levels at moderate levels of pain severity. Sleep quality did not appear to 
strongly affect fatigue levels when youth experienced no pain or mild pain the day prior. 
Of note, Ameringer and Smith (2011) had proposed that sleep might mediate the 
relationship between pain and fatigue. Findings from the current study and limited 
research supporting a causal impact of pain on subjective sleep quality support that sleep 
instead interacts with pain to exert a synergistic effect on fatigue levels. These findings 
are further supported by the pathophysiology of sickle cell disease. Specifically, vaso-





systemic inflammation, likely contributing to increased levels of fatigue among patients 
(Gutstein, 2001; Reese et al., 2010).  
These results underscore the importance of intervening with youth who 
demonstrate high levels of pain and poor sleep quality. While both of these factors 
predict increased fatigue in youth, the combination of these factors leads to even greater 
levels of fatigue, which subsequently put youth at risk for functional disability, poor 
QOL, and challenges in school (Anderson, et al. 2015; Dampier et al., 2010; Rogers & 
Lance, 2017).  For youth reporting high levels of fatigue, providers should thoroughly 
assess patients’ pain management strategies and sleep habits. Behavioral and 
pharmacological interventions that target pain management and sleep hygiene may 
produce ameliorative effects on fatigue levels and restore youth’s functional ability.  
Finally, in line with the goal to identify novel predictors of fatigue in youth with 
SCD, the effect of pain medication on prospective fatigue levels was examined. This aim 
was particularly important for two reasons: the dearth of literature examining the effects 
of pain medications on fatigue levels among youth with chronic illness and the 
widespread failure for prior research studies to account for the effects of pain 
medications. As expected, use of non-opioid pain medications did not predict increases in 
next-day fatigue levels. However, contrary to hypothesis 3c, opioid pain medications also 
did not predict increases in prospective fatigue levels. Non-opioid pain medications 
include non-steroidal anti-inflammatory drugs (NSAIDs), non-opioid analgesics 
(acetaminophen), and topical medications (Okpala & Tawil, 2002). Side effects of these 
medications are typically restricted to renal, gastrointestinal, and cardiovascular 





sickle cell disease (Harirforoosh, Asghar, & Jamali, 2013). Opioid medications, however, 
exert a powerful sedative effect. Their association with fatigue levels among patients with 
significant pain disorders remains unclear (Ameringer et al., 2014; Fishbain et al., 2005; 
Valrie et al., 2007). Delays between high plasma concentration of opioids and perceived 
effects can last up to an hour (Lotsch, 2005). Additionally, the half-lives of long-acting 
opioids may last up to seven hours and short acting opioids commonly used to treat 
pediatric sickle cell pain (Ballas, 2011) have half-lives of three to four hours (Lotsch, 
2005). Sedative effects of opioids used to treat pain crises, therefore, could persist for a 
duration that spans multiple days. However, in a review of medications proposed to affect 
fatigue levels among patients, opioids were not thought to significantly contribute to 
persistent levels of fatigue (Zlyott & Byrne, 2010). Because the timeframe under which 
opioids affect fatigue levels may be restricted, it is possible that researchers are instead 
interested in how other drugs, whose side effects may include anemia, affect fatigue 
levels among patients. However, based on the half-life of opioid pain medications, it 
seems plausible that opioids taken for pain management could affect next-day levels of 
fatigue.  
Evidence supporting opioids’ potentially long-acting sedative effects suggest that 
our findings could be explained by measurement error or study limitations. Specifically, 
few participants reported days in which they experienced severe pain and took opioid 
medications. Our study could be underpowered to detect a significant effect of these 
medications on prospective fatigue levels. Additionally, participants did not specify 
which type of opioid they took. Controlling for differences in dosage, potency, and the 





participants were only given three options which specified whether they took non-opioid, 
opioid, or no medication daily. It is possible that some patients reported taking non-
opioid drugs when they instead took both non-opioid and opioid drugs, which is the 
recommended sequence for managing sickle cell pain (Ballas, 2011). Alternatively, it 
could be that short half-lives mitigate persistent sedative effects of opioid pain 
medications. Future researchers should carefully examine next-day effects of opioid use 
on fatigue levels, functional disability, and mood among sickle cell patients.  
Limitations are important to consider when evaluating findings from the present 
study. Daily diary studies typically involve small sample sizes and although studies may 
be adequately powered to detect clinically meaningful associations between constructs, 
findings may not generalize to the broader population. These limitations, in part, explain 
why replication of prior findings are important and necessary to extend the research 
literature. Future studies should attempt to replicate research findings with larger samples 
including sickle cell patients of varying age, genotype, and location within the US. 
Additionally, most participants provided data with missing days and diary information. 
Although participants who completed few diary entries were excluded from the present 
study, it is likely that some patients did not complete diaries on days with meaningful 
data, such as high levels of pain. It is possible that effect sizes and associations between 
variables may be underestimated. Researchers should identify effective strategies to boost 
adherence rates for diary completion and recommend standardized procedures that can be 
used for daily diary studies. Along these lines, at present, there is limited understanding 
of how diary completers may differ from diary non-completers as well as how 





researchers can elucidate these differences or lack thereof, conservative estimates of the 
generalizability of findings from daily diary studies are warranted. Another limitation to 
the present study was the use of self-report data. While our primary interests were 
concerned with subjective ratings of fatigue, sleep quality, and pain severity, including 
additional objective measures of these constructs is important. Alternatively, collecting 
parent ratings of youth’s pain, fatigue, and sleep quality could provide useful information 
for researchers. Finally, although we used a daily measure of fatigue that was similar to 
measures used in previous research (Ream et al., 2006; Schwartz, 2000), the reliability 
and validity of our measure of daily fatigue should be explored. Researchers and 
clinicians should work to develop an agreed-upon definition of fatigue among sickle cell 
patients to aid in advancing understanding of this construct and its effects on patients.     
In summary, these data supported the generalizability of prior research findings 
and countered generalizability of others regarding relationships between pain, mood, 
fatigue, and sleep. The relationship or lack thereof between negative affect and pain 
severity should be better characterized by future research. Additionally, future research 
should attempt to replicate analyses from the present study while addressing 
methodological inconsistencies in order to better characterize associations between these 
variables. This thesis also identified novel relations among variables of sleep, pain, 
fatigue, and use of pain medications. Specifically, sleep was found to independently 
predict fatigue and interact with moderate levels of pain to predict prospective fatigue 
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Figure A. 5 Model assumptions for H3 
 
 
 
 
 
 
 
 
 
